Dr. McKown joined the University of Wisconsin School of Medicine and Public Health faculty in 2000. He received his medical degree from the Wayne State University School of Medicine, where he also did his internship. After serving four years in the United States Navy as a Primary Care Medical Officer, Dr. McKown completed his internal medicine and rheumatology training at the University of Tennessee. Dr. McKown joined the faculty of the University of Tennessee College of Medicine in 1992.
Dr. McKown has been actively involved in Medical education throughout his career. He is currently Co-Director of the UW Internal Medicine Clerkship and Program Director of the UW Rheumatology Fellowship.
His current research interests are clinical aspects of scleroderma and stem cell transplantation therapy for autoimmune rheumatic disorders.
His areas of clinical interest include rheumatic manifestations of viral infections, polymyositis, autoinflammatory diseases including CRMO, SAPHO, Blau Syndrome and the periodic fever syndromes as well as scleroderma.
Search for Kevin McKown's literature abstracts on PubMed
Hashim G, Pope JE, Clements P, Medsger TA, Martin RW, Merkel P, Kahaleh B, Wollheim F, Baron M, Csuka ME, Emery P, Belch JF, Hayat S, Lally EV, Korn JH, Czirjak L, Herrick A, Voskuyl AE, Bruhlmann P, Inanc M, Furst DE, Black C, Ellman M, Moerland LW, Rothfield NF, Hsu V, Mayes M, McKown KM, Krieg T, Seibold JR. Outcome measurements in scleroderma: results from a delphi exercise. J. Rheumatol 2007 Mar; 34(3):501-9.
Carbone L, Tylavsky F, Wan J, McKown K, Cheng S. Bone mineral density in scleroderma. Rheumatology (Oxford) 1999 Apr; 38(4): 371-2.
McKown KM, Carbone LD, Kaplan SB, Aelion JA, Lohr KL, Cremer MA, Bustillo J, Gonzalez M, Kaeley G, Steere EL, Somes GW, Myers LK, Seyer JM, Kang AH, Postlethwaite AE. Oral bovine type II collagen added to existing therapy in rheumatoid arthritis is not efficacious. Arthritis Rheum 1999 Jun; 42(6):1204-1208.
McKown KM, Carbone LD, Bustillo J, Seyer JM, Kang AH, Postlethwaite AE. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis Rheum 2000 May; 43(5):1054-1061
Monier P, McKown K, Bronze MS. Osteonecrosis of bone complicating highly active antiretroviral therapy in HIV infected patients. Clin Infect Dis 2000 Dec; 31(6):1488-1492.
Carbone LD, McKown K, Pugazherthim, Barrow KD, Warrington K, Sornes G, Postlethwaite A. Dose effects of orally administered bovine type I collagen on immune function in patients with systemic sclerosis. Arthritis Rheum 2004 Aug; 50(8):2713-5.